Online inquiry

IVTScrip™ mRNA-Human ARIH2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25630MR)

This product GTTS-WK25630MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ARIH2 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001317333.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10425
UniProt ID O95376
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARIH2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK25630MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK26115MR IVTScrip™ mRNA-Human APOA1BP, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA APOA1BP
GTTS-WK7610MR IVTScrip™ mRNA-Human ACADVL, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACADVL
GTTS-WK25713MR IVTScrip™ mRNA-Human ASH2L, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASH2L
GTTS-WK22454MR IVTScrip™ mRNA-Human ATG13, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ATG13
GTTS-WK5926MR IVTScrip™ mRNA-Human CD73, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA CD73
GTTS-WK12409MR IVTScrip™ mRNA-Human ACADSB, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACADSB
GTTS-WK20216MR IVTScrip™ mRNA-Human ALG5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ALG5
GTTS-WK16013MR IVTScrip™ mRNA-Human ALG13, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALG13
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →